nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP11A1—uterine cancer	0.348	0.659	CbGaD
Terbinafine—CYP19A1—uterine cancer	0.18	0.341	CbGaD
Terbinafine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0453	0.157	CbGbCtD
Terbinafine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0316	0.11	CbGbCtD
Terbinafine—CYP2C8—Progesterone—uterine cancer	0.03	0.104	CbGbCtD
Terbinafine—CYP2C19—Progesterone—uterine cancer	0.0252	0.0874	CbGbCtD
Terbinafine—PTGS1—Etoposide—uterine cancer	0.0233	0.0808	CbGbCtD
Terbinafine—CYP1A2—Progesterone—uterine cancer	0.0233	0.0807	CbGbCtD
Terbinafine—CYP2C9—Progesterone—uterine cancer	0.021	0.0727	CbGbCtD
Terbinafine—CYP2D6—Progesterone—uterine cancer	0.0192	0.0664	CbGbCtD
Terbinafine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0184	0.0638	CbGbCtD
Terbinafine—CYP2C8—Etoposide—uterine cancer	0.0134	0.0466	CbGbCtD
Terbinafine—CYP3A4—Progesterone—uterine cancer	0.0122	0.0423	CbGbCtD
Terbinafine—CYP11A1—corpus luteum—uterine cancer	0.0119	0.24	CbGeAlD
Terbinafine—CYP1A2—Etoposide—uterine cancer	0.0104	0.0361	CbGbCtD
Terbinafine—CYP19A1—corpus luteum—uterine cancer	0.00775	0.156	CbGeAlD
Terbinafine—CYP2D6—Doxorubicin—uterine cancer	0.00585	0.0203	CbGbCtD
Terbinafine—CYP3A4—Etoposide—uterine cancer	0.00545	0.0189	CbGbCtD
Terbinafine—CYP3A4—Doxorubicin—uterine cancer	0.00372	0.0129	CbGbCtD
Terbinafine—CYP19A1—semen—uterine cancer	0.00363	0.0731	CbGeAlD
Terbinafine—SQLE—uterine cervix—uterine cancer	0.00156	0.0314	CbGeAlD
Terbinafine—PTGS1—oviduct—uterine cancer	0.00155	0.0311	CbGeAlD
Terbinafine—SQLE—decidua—uterine cancer	0.00148	0.0299	CbGeAlD
Terbinafine—SQLE—endometrium—uterine cancer	0.00141	0.0284	CbGeAlD
Terbinafine—SQLE—mammalian vulva—uterine cancer	0.00136	0.0274	CbGeAlD
Terbinafine—SQLE—uterus—uterine cancer	0.0013	0.0261	CbGeAlD
Terbinafine—SQLE—female reproductive system—uterine cancer	0.00117	0.0235	CbGeAlD
Terbinafine—SQLE—female gonad—uterine cancer	0.00106	0.0214	CbGeAlD
Terbinafine—SQLE—vagina—uterine cancer	0.00105	0.0212	CbGeAlD
Terbinafine—PTGS1—artery—uterine cancer	0.00102	0.0206	CbGeAlD
Terbinafine—CYP11A1—decidua—uterine cancer	0.000972	0.0196	CbGeAlD
Terbinafine—CYP11A1—female reproductive system—uterine cancer	0.000764	0.0154	CbGeAlD
Terbinafine—CYP11A1—female gonad—uterine cancer	0.000695	0.014	CbGeAlD
Terbinafine—SQLE—lymph node—uterine cancer	0.000682	0.0137	CbGeAlD
Terbinafine—CYP19A1—endometrium—uterine cancer	0.000599	0.0121	CbGeAlD
Terbinafine—CYP19A1—uterus—uterine cancer	0.000552	0.0111	CbGeAlD
Terbinafine—CYP19A1—female reproductive system—uterine cancer	0.000497	0.01	CbGeAlD
Terbinafine—CYP19A1—female gonad—uterine cancer	0.000452	0.0091	CbGeAlD
Terbinafine—CYP11A1—lymph node—uterine cancer	0.000447	0.00901	CbGeAlD
Terbinafine—CYP2C8—renal system—uterine cancer	0.000444	0.00894	CbGeAlD
Terbinafine—CYP2C8—endometrium—uterine cancer	0.000429	0.00865	CbGeAlD
Terbinafine—CYP1A2—renal system—uterine cancer	0.000415	0.00837	CbGeAlD
Terbinafine—PTGS1—epithelium—uterine cancer	0.000388	0.00782	CbGeAlD
Terbinafine—PTGS1—uterine cervix—uterine cancer	0.000385	0.00775	CbGeAlD
Terbinafine—PTGS1—smooth muscle tissue—uterine cancer	0.000374	0.00753	CbGeAlD
Terbinafine—CYP2C19—vagina—uterine cancer	0.000368	0.00742	CbGeAlD
Terbinafine—PTGS1—renal system—uterine cancer	0.00036	0.00725	CbGeAlD
Terbinafine—CYP2C8—female reproductive system—uterine cancer	0.000356	0.00716	CbGeAlD
Terbinafine—PTGS1—endometrium—uterine cancer	0.000348	0.00701	CbGeAlD
Terbinafine—PTGS1—mammalian vulva—uterine cancer	0.000337	0.00678	CbGeAlD
Terbinafine—CYP2C8—vagina—uterine cancer	0.000322	0.00648	CbGeAlD
Terbinafine—PTGS1—uterus—uterine cancer	0.000321	0.00646	CbGeAlD
Terbinafine—CYP2C9—female reproductive system—uterine cancer	0.000316	0.00636	CbGeAlD
Terbinafine—CYP3A4—renal system—uterine cancer	0.000301	0.00606	CbGeAlD
Terbinafine—CYP2D6—renal system—uterine cancer	0.000296	0.00596	CbGeAlD
Terbinafine—CYP19A1—lymph node—uterine cancer	0.00029	0.00585	CbGeAlD
Terbinafine—PTGS1—female reproductive system—uterine cancer	0.000288	0.00581	CbGeAlD
Terbinafine—PTGS1—female gonad—uterine cancer	0.000262	0.00529	CbGeAlD
Terbinafine—PTGS1—vagina—uterine cancer	0.000261	0.00525	CbGeAlD
Terbinafine—CYP3A4—female reproductive system—uterine cancer	0.000241	0.00485	CbGeAlD
Terbinafine—CYP2D6—female reproductive system—uterine cancer	0.000237	0.00477	CbGeAlD
Terbinafine—CYP2D6—female gonad—uterine cancer	0.000216	0.00434	CbGeAlD
Terbinafine—Influenza like illness—Doxorubicin—uterine cancer	0.000169	0.00176	CcSEcCtD
Terbinafine—PTGS1—lymph node—uterine cancer	0.000169	0.0034	CbGeAlD
Terbinafine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000168	0.00176	CcSEcCtD
Terbinafine—Asthenia—Progesterone—uterine cancer	0.000168	0.00175	CcSEcCtD
Terbinafine—Hypoaesthesia—Etoposide—uterine cancer	0.000168	0.00175	CcSEcCtD
Terbinafine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000168	0.00175	CcSEcCtD
Terbinafine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000168	0.00175	CcSEcCtD
Terbinafine—Skin exfoliation—Doxorubicin—uterine cancer	0.000166	0.00173	CcSEcCtD
Terbinafine—Pruritus—Progesterone—uterine cancer	0.000166	0.00173	CcSEcCtD
Terbinafine—Infection—Dactinomycin—uterine cancer	0.000164	0.00172	CcSEcCtD
Terbinafine—Blood urea increased—Doxorubicin—uterine cancer	0.000164	0.00172	CcSEcCtD
Terbinafine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000162	0.00169	CcSEcCtD
Terbinafine—Diarrhoea—Progesterone—uterine cancer	0.00016	0.00167	CcSEcCtD
Terbinafine—Erythema multiforme—Etoposide—uterine cancer	0.000159	0.00166	CcSEcCtD
Terbinafine—Anorexia—Dactinomycin—uterine cancer	0.000158	0.00165	CcSEcCtD
Terbinafine—Eye disorder—Etoposide—uterine cancer	0.000157	0.00164	CcSEcCtD
Terbinafine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000156	0.00163	CcSEcCtD
Terbinafine—Hepatic function abnormal—Epirubicin—uterine cancer	0.000156	0.00163	CcSEcCtD
Terbinafine—Photosensitivity—Epirubicin—uterine cancer	0.000155	0.00162	CcSEcCtD
Terbinafine—Dizziness—Progesterone—uterine cancer	0.000155	0.00162	CcSEcCtD
Terbinafine—Angiopathy—Etoposide—uterine cancer	0.000153	0.0016	CcSEcCtD
Terbinafine—Immune system disorder—Etoposide—uterine cancer	0.000152	0.00159	CcSEcCtD
Terbinafine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000152	0.00159	CcSEcCtD
Terbinafine—Hepatic failure—Epirubicin—uterine cancer	0.000152	0.00159	CcSEcCtD
Terbinafine—Eczema—Epirubicin—uterine cancer	0.000152	0.00159	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000151	0.00157	CcSEcCtD
Terbinafine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00015	0.00157	CcSEcCtD
Terbinafine—Alopecia—Etoposide—uterine cancer	0.000149	0.00155	CcSEcCtD
Terbinafine—Vomiting—Progesterone—uterine cancer	0.000149	0.00155	CcSEcCtD
Terbinafine—Rash—Progesterone—uterine cancer	0.000147	0.00154	CcSEcCtD
Terbinafine—Dermatitis—Progesterone—uterine cancer	0.000147	0.00154	CcSEcCtD
Terbinafine—Headache—Progesterone—uterine cancer	0.000147	0.00153	CcSEcCtD
Terbinafine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000145	0.00151	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000145	0.00151	CcSEcCtD
Terbinafine—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000144	0.00151	CcSEcCtD
Terbinafine—Photosensitivity—Doxorubicin—uterine cancer	0.000144	0.0015	CcSEcCtD
Terbinafine—Decreased appetite—Dactinomycin—uterine cancer	0.000144	0.0015	CcSEcCtD
Terbinafine—Dysgeusia—Etoposide—uterine cancer	0.000144	0.0015	CcSEcCtD
Terbinafine—Dermatitis bullous—Epirubicin—uterine cancer	0.000143	0.00149	CcSEcCtD
Terbinafine—Fatigue—Dactinomycin—uterine cancer	0.000143	0.00149	CcSEcCtD
Terbinafine—Pain—Dactinomycin—uterine cancer	0.000141	0.00148	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000141	0.00147	CcSEcCtD
Terbinafine—Muscle spasms—Etoposide—uterine cancer	0.000141	0.00147	CcSEcCtD
Terbinafine—Eczema—Doxorubicin—uterine cancer	0.000141	0.00147	CcSEcCtD
Terbinafine—Hepatic failure—Doxorubicin—uterine cancer	0.000141	0.00147	CcSEcCtD
Terbinafine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00014	0.00146	CcSEcCtD
Terbinafine—Hypoglycaemia—Epirubicin—uterine cancer	0.00014	0.00146	CcSEcCtD
Terbinafine—Nausea—Progesterone—uterine cancer	0.000139	0.00145	CcSEcCtD
Terbinafine—Feeling abnormal—Dactinomycin—uterine cancer	0.000136	0.00142	CcSEcCtD
Terbinafine—Ill-defined disorder—Etoposide—uterine cancer	0.000136	0.00142	CcSEcCtD
Terbinafine—Anaemia—Etoposide—uterine cancer	0.000136	0.00142	CcSEcCtD
Terbinafine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000135	0.00141	CcSEcCtD
Terbinafine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000135	0.00141	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000134	0.0014	CcSEcCtD
Terbinafine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000134	0.0014	CcSEcCtD
Terbinafine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000134	0.00139	CcSEcCtD
Terbinafine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000133	0.00139	CcSEcCtD
Terbinafine—Malaise—Etoposide—uterine cancer	0.000132	0.00138	CcSEcCtD
Terbinafine—Dermatitis bullous—Doxorubicin—uterine cancer	0.000132	0.00138	CcSEcCtD
Terbinafine—Vertigo—Etoposide—uterine cancer	0.000132	0.00138	CcSEcCtD
Terbinafine—Abdominal pain—Dactinomycin—uterine cancer	0.000131	0.00136	CcSEcCtD
Terbinafine—Body temperature increased—Dactinomycin—uterine cancer	0.000131	0.00136	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00013	0.00136	CcSEcCtD
Terbinafine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000129	0.00135	CcSEcCtD
Terbinafine—Cough—Etoposide—uterine cancer	0.000128	0.00134	CcSEcCtD
Terbinafine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000126	0.00131	CcSEcCtD
Terbinafine—Chest pain—Etoposide—uterine cancer	0.000125	0.0013	CcSEcCtD
Terbinafine—Abdominal pain upper—Epirubicin—uterine cancer	0.000125	0.0013	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000124	0.00129	CcSEcCtD
Terbinafine—Discomfort—Etoposide—uterine cancer	0.000123	0.00129	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000123	0.00128	CcSEcCtD
Terbinafine—Nasopharyngitis—Epirubicin—uterine cancer	0.000122	0.00127	CcSEcCtD
Terbinafine—Hypersensitivity—Dactinomycin—uterine cancer	0.000122	0.00127	CcSEcCtD
Terbinafine—Gastritis—Epirubicin—uterine cancer	0.000121	0.00126	CcSEcCtD
Terbinafine—Confusional state—Etoposide—uterine cancer	0.000121	0.00126	CcSEcCtD
Terbinafine—Anaphylactic shock—Etoposide—uterine cancer	0.00012	0.00125	CcSEcCtD
Terbinafine—Infection—Etoposide—uterine cancer	0.000119	0.00124	CcSEcCtD
Terbinafine—Asthenia—Dactinomycin—uterine cancer	0.000119	0.00124	CcSEcCtD
Terbinafine—Influenza—Epirubicin—uterine cancer	0.000118	0.00123	CcSEcCtD
Terbinafine—Thrombocytopenia—Etoposide—uterine cancer	0.000117	0.00122	CcSEcCtD
Terbinafine—Eosinophilia—Epirubicin—uterine cancer	0.000117	0.00122	CcSEcCtD
Terbinafine—Skin disorder—Etoposide—uterine cancer	0.000116	0.00121	CcSEcCtD
Terbinafine—Pancreatitis—Epirubicin—uterine cancer	0.000116	0.00121	CcSEcCtD
Terbinafine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000115	0.0012	CcSEcCtD
Terbinafine—Anorexia—Etoposide—uterine cancer	0.000114	0.00119	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000114	0.00119	CcSEcCtD
Terbinafine—Diarrhoea—Dactinomycin—uterine cancer	0.000113	0.00118	CcSEcCtD
Terbinafine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000113	0.00118	CcSEcCtD
Terbinafine—Pancytopenia—Epirubicin—uterine cancer	0.000112	0.00117	CcSEcCtD
Terbinafine—Gastritis—Doxorubicin—uterine cancer	0.000112	0.00117	CcSEcCtD
Terbinafine—Neutropenia—Epirubicin—uterine cancer	0.00011	0.00115	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00011	0.00114	CcSEcCtD
Terbinafine—Influenza—Doxorubicin—uterine cancer	0.000109	0.00114	CcSEcCtD
Terbinafine—Eosinophilia—Doxorubicin—uterine cancer	0.000108	0.00113	CcSEcCtD
Terbinafine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000108	0.00112	CcSEcCtD
Terbinafine—Paraesthesia—Etoposide—uterine cancer	0.000107	0.00112	CcSEcCtD
Terbinafine—Pancreatitis—Doxorubicin—uterine cancer	0.000107	0.00112	CcSEcCtD
Terbinafine—Weight decreased—Epirubicin—uterine cancer	0.000107	0.00111	CcSEcCtD
Terbinafine—Infestation NOS—Epirubicin—uterine cancer	0.000105	0.0011	CcSEcCtD
Terbinafine—Infestation—Epirubicin—uterine cancer	0.000105	0.0011	CcSEcCtD
Terbinafine—Vomiting—Dactinomycin—uterine cancer	0.000105	0.0011	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000104	0.00109	CcSEcCtD
Terbinafine—Rash—Dactinomycin—uterine cancer	0.000104	0.00109	CcSEcCtD
Terbinafine—Decreased appetite—Etoposide—uterine cancer	0.000104	0.00109	CcSEcCtD
Terbinafine—Pancytopenia—Doxorubicin—uterine cancer	0.000104	0.00108	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000103	0.00108	CcSEcCtD
Terbinafine—Fatigue—Etoposide—uterine cancer	0.000103	0.00108	CcSEcCtD
Terbinafine—Jaundice—Epirubicin—uterine cancer	0.000103	0.00107	CcSEcCtD
Terbinafine—Pain—Etoposide—uterine cancer	0.000102	0.00107	CcSEcCtD
Terbinafine—Neutropenia—Doxorubicin—uterine cancer	0.000102	0.00107	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000101	0.00106	CcSEcCtD
Terbinafine—Photosensitivity reaction—Doxorubicin—uterine cancer	9.96e-05	0.00104	CcSEcCtD
Terbinafine—Hepatobiliary disease—Epirubicin—uterine cancer	9.95e-05	0.00104	CcSEcCtD
Terbinafine—Weight decreased—Doxorubicin—uterine cancer	9.87e-05	0.00103	CcSEcCtD
Terbinafine—Feeling abnormal—Etoposide—uterine cancer	9.86e-05	0.00103	CcSEcCtD
Terbinafine—Nausea—Dactinomycin—uterine cancer	9.82e-05	0.00103	CcSEcCtD
Terbinafine—Agranulocytosis—Epirubicin—uterine cancer	9.81e-05	0.00102	CcSEcCtD
Terbinafine—Gastrointestinal pain—Etoposide—uterine cancer	9.79e-05	0.00102	CcSEcCtD
Terbinafine—Infestation NOS—Doxorubicin—uterine cancer	9.73e-05	0.00102	CcSEcCtD
Terbinafine—Infestation—Doxorubicin—uterine cancer	9.73e-05	0.00102	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	9.65e-05	0.00101	CcSEcCtD
Terbinafine—Urticaria—Etoposide—uterine cancer	9.51e-05	0.000993	CcSEcCtD
Terbinafine—Jaundice—Doxorubicin—uterine cancer	9.49e-05	0.000991	CcSEcCtD
Terbinafine—Abdominal pain—Etoposide—uterine cancer	9.46e-05	0.000988	CcSEcCtD
Terbinafine—Body temperature increased—Etoposide—uterine cancer	9.46e-05	0.000988	CcSEcCtD
Terbinafine—Hepatitis—Epirubicin—uterine cancer	9.44e-05	0.000986	CcSEcCtD
Terbinafine—Hypoaesthesia—Epirubicin—uterine cancer	9.39e-05	0.000981	CcSEcCtD
Terbinafine—Connective tissue disorder—Epirubicin—uterine cancer	9.28e-05	0.000969	CcSEcCtD
Terbinafine—Hepatobiliary disease—Doxorubicin—uterine cancer	9.2e-05	0.000961	CcSEcCtD
Terbinafine—Visual impairment—Epirubicin—uterine cancer	9.1e-05	0.00095	CcSEcCtD
Terbinafine—Agranulocytosis—Doxorubicin—uterine cancer	9.08e-05	0.000948	CcSEcCtD
Terbinafine—Erythema multiforme—Epirubicin—uterine cancer	8.93e-05	0.000932	CcSEcCtD
Terbinafine—Eye disorder—Epirubicin—uterine cancer	8.82e-05	0.000921	CcSEcCtD
Terbinafine—Hypersensitivity—Etoposide—uterine cancer	8.82e-05	0.000921	CcSEcCtD
Terbinafine—Tinnitus—Epirubicin—uterine cancer	8.8e-05	0.000919	CcSEcCtD
Terbinafine—Hepatitis—Doxorubicin—uterine cancer	8.74e-05	0.000912	CcSEcCtD
Terbinafine—Hypoaesthesia—Doxorubicin—uterine cancer	8.69e-05	0.000908	CcSEcCtD
Terbinafine—Asthenia—Etoposide—uterine cancer	8.59e-05	0.000897	CcSEcCtD
Terbinafine—Connective tissue disorder—Doxorubicin—uterine cancer	8.58e-05	0.000897	CcSEcCtD
Terbinafine—Angiopathy—Epirubicin—uterine cancer	8.57e-05	0.000895	CcSEcCtD
Terbinafine—Immune system disorder—Epirubicin—uterine cancer	8.53e-05	0.000891	CcSEcCtD
Terbinafine—Pruritus—Etoposide—uterine cancer	8.47e-05	0.000884	CcSEcCtD
Terbinafine—Visual impairment—Doxorubicin—uterine cancer	8.42e-05	0.000879	CcSEcCtD
Terbinafine—Alopecia—Epirubicin—uterine cancer	8.34e-05	0.000871	CcSEcCtD
Terbinafine—Mental disorder—Epirubicin—uterine cancer	8.27e-05	0.000864	CcSEcCtD
Terbinafine—Erythema multiforme—Doxorubicin—uterine cancer	8.26e-05	0.000863	CcSEcCtD
Terbinafine—Erythema—Epirubicin—uterine cancer	8.22e-05	0.000858	CcSEcCtD
Terbinafine—Diarrhoea—Etoposide—uterine cancer	8.19e-05	0.000855	CcSEcCtD
Terbinafine—Eye disorder—Doxorubicin—uterine cancer	8.16e-05	0.000853	CcSEcCtD
Terbinafine—Tinnitus—Doxorubicin—uterine cancer	8.15e-05	0.000851	CcSEcCtD
Terbinafine—Flatulence—Epirubicin—uterine cancer	8.1e-05	0.000846	CcSEcCtD
Terbinafine—Dysgeusia—Epirubicin—uterine cancer	8.05e-05	0.000841	CcSEcCtD
Terbinafine—Angiopathy—Doxorubicin—uterine cancer	7.93e-05	0.000828	CcSEcCtD
Terbinafine—Dizziness—Etoposide—uterine cancer	7.91e-05	0.000826	CcSEcCtD
Terbinafine—Muscle spasms—Epirubicin—uterine cancer	7.9e-05	0.000825	CcSEcCtD
Terbinafine—Immune system disorder—Doxorubicin—uterine cancer	7.89e-05	0.000824	CcSEcCtD
Terbinafine—Vision blurred—Epirubicin—uterine cancer	7.75e-05	0.000809	CcSEcCtD
Terbinafine—Alopecia—Doxorubicin—uterine cancer	7.72e-05	0.000806	CcSEcCtD
Terbinafine—Mental disorder—Doxorubicin—uterine cancer	7.65e-05	0.000799	CcSEcCtD
Terbinafine—Ill-defined disorder—Epirubicin—uterine cancer	7.63e-05	0.000796	CcSEcCtD
Terbinafine—Vomiting—Etoposide—uterine cancer	7.61e-05	0.000795	CcSEcCtD
Terbinafine—Erythema—Doxorubicin—uterine cancer	7.6e-05	0.000794	CcSEcCtD
Terbinafine—Anaemia—Epirubicin—uterine cancer	7.6e-05	0.000793	CcSEcCtD
Terbinafine—Rash—Etoposide—uterine cancer	7.55e-05	0.000788	CcSEcCtD
Terbinafine—Dermatitis—Etoposide—uterine cancer	7.54e-05	0.000787	CcSEcCtD
Terbinafine—Headache—Etoposide—uterine cancer	7.5e-05	0.000783	CcSEcCtD
Terbinafine—Flatulence—Doxorubicin—uterine cancer	7.49e-05	0.000783	CcSEcCtD
Terbinafine—Dysgeusia—Doxorubicin—uterine cancer	7.45e-05	0.000778	CcSEcCtD
Terbinafine—Malaise—Epirubicin—uterine cancer	7.41e-05	0.000774	CcSEcCtD
Terbinafine—Vertigo—Epirubicin—uterine cancer	7.38e-05	0.000771	CcSEcCtD
Terbinafine—Muscle spasms—Doxorubicin—uterine cancer	7.31e-05	0.000764	CcSEcCtD
Terbinafine—Cough—Epirubicin—uterine cancer	7.17e-05	0.000749	CcSEcCtD
Terbinafine—Vision blurred—Doxorubicin—uterine cancer	7.17e-05	0.000748	CcSEcCtD
Terbinafine—Nausea—Etoposide—uterine cancer	7.11e-05	0.000742	CcSEcCtD
Terbinafine—Ill-defined disorder—Doxorubicin—uterine cancer	7.06e-05	0.000737	CcSEcCtD
Terbinafine—Anaemia—Doxorubicin—uterine cancer	7.03e-05	0.000734	CcSEcCtD
Terbinafine—Arthralgia—Epirubicin—uterine cancer	7e-05	0.000731	CcSEcCtD
Terbinafine—Myalgia—Epirubicin—uterine cancer	7e-05	0.000731	CcSEcCtD
Terbinafine—Chest pain—Epirubicin—uterine cancer	7e-05	0.000731	CcSEcCtD
Terbinafine—Anxiety—Epirubicin—uterine cancer	6.97e-05	0.000728	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	6.95e-05	0.000726	CcSEcCtD
Terbinafine—Discomfort—Epirubicin—uterine cancer	6.91e-05	0.000722	CcSEcCtD
Terbinafine—Malaise—Doxorubicin—uterine cancer	6.86e-05	0.000716	CcSEcCtD
Terbinafine—Dry mouth—Epirubicin—uterine cancer	6.84e-05	0.000715	CcSEcCtD
Terbinafine—Vertigo—Doxorubicin—uterine cancer	6.83e-05	0.000714	CcSEcCtD
Terbinafine—Confusional state—Epirubicin—uterine cancer	6.76e-05	0.000706	CcSEcCtD
Terbinafine—Anaphylactic shock—Epirubicin—uterine cancer	6.71e-05	0.000701	CcSEcCtD
Terbinafine—Infection—Epirubicin—uterine cancer	6.66e-05	0.000696	CcSEcCtD
Terbinafine—Cough—Doxorubicin—uterine cancer	6.64e-05	0.000693	CcSEcCtD
Terbinafine—Nervous system disorder—Epirubicin—uterine cancer	6.58e-05	0.000687	CcSEcCtD
Terbinafine—Thrombocytopenia—Epirubicin—uterine cancer	6.57e-05	0.000686	CcSEcCtD
Terbinafine—Skin disorder—Epirubicin—uterine cancer	6.52e-05	0.00068	CcSEcCtD
Terbinafine—Arthralgia—Doxorubicin—uterine cancer	6.47e-05	0.000676	CcSEcCtD
Terbinafine—Chest pain—Doxorubicin—uterine cancer	6.47e-05	0.000676	CcSEcCtD
Terbinafine—Myalgia—Doxorubicin—uterine cancer	6.47e-05	0.000676	CcSEcCtD
Terbinafine—Anxiety—Doxorubicin—uterine cancer	6.45e-05	0.000674	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	6.43e-05	0.000671	CcSEcCtD
Terbinafine—Discomfort—Doxorubicin—uterine cancer	6.4e-05	0.000668	CcSEcCtD
Terbinafine—Anorexia—Epirubicin—uterine cancer	6.39e-05	0.000668	CcSEcCtD
Terbinafine—Dry mouth—Doxorubicin—uterine cancer	6.33e-05	0.000661	CcSEcCtD
Terbinafine—Confusional state—Doxorubicin—uterine cancer	6.26e-05	0.000654	CcSEcCtD
Terbinafine—Anaphylactic shock—Doxorubicin—uterine cancer	6.21e-05	0.000648	CcSEcCtD
Terbinafine—Infection—Doxorubicin—uterine cancer	6.17e-05	0.000644	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.11e-05	0.000638	CcSEcCtD
Terbinafine—Nervous system disorder—Doxorubicin—uterine cancer	6.09e-05	0.000636	CcSEcCtD
Terbinafine—Thrombocytopenia—Doxorubicin—uterine cancer	6.08e-05	0.000635	CcSEcCtD
Terbinafine—Skin disorder—Doxorubicin—uterine cancer	6.03e-05	0.00063	CcSEcCtD
Terbinafine—Paraesthesia—Epirubicin—uterine cancer	6.02e-05	0.000629	CcSEcCtD
Terbinafine—Anorexia—Doxorubicin—uterine cancer	5.92e-05	0.000618	CcSEcCtD
Terbinafine—Dyspepsia—Epirubicin—uterine cancer	5.9e-05	0.000617	CcSEcCtD
Terbinafine—Decreased appetite—Epirubicin—uterine cancer	5.83e-05	0.000609	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Epirubicin—uterine cancer	5.79e-05	0.000605	CcSEcCtD
Terbinafine—Fatigue—Epirubicin—uterine cancer	5.78e-05	0.000604	CcSEcCtD
Terbinafine—Pain—Epirubicin—uterine cancer	5.74e-05	0.000599	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.65e-05	0.000591	CcSEcCtD
Terbinafine—Paraesthesia—Doxorubicin—uterine cancer	5.57e-05	0.000582	CcSEcCtD
Terbinafine—Feeling abnormal—Epirubicin—uterine cancer	5.53e-05	0.000577	CcSEcCtD
Terbinafine—Gastrointestinal pain—Epirubicin—uterine cancer	5.49e-05	0.000573	CcSEcCtD
Terbinafine—Dyspepsia—Doxorubicin—uterine cancer	5.46e-05	0.000571	CcSEcCtD
Terbinafine—Decreased appetite—Doxorubicin—uterine cancer	5.4e-05	0.000563	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.36e-05	0.00056	CcSEcCtD
Terbinafine—Fatigue—Doxorubicin—uterine cancer	5.35e-05	0.000559	CcSEcCtD
Terbinafine—Urticaria—Epirubicin—uterine cancer	5.33e-05	0.000557	CcSEcCtD
Terbinafine—Pain—Doxorubicin—uterine cancer	5.31e-05	0.000554	CcSEcCtD
Terbinafine—Abdominal pain—Epirubicin—uterine cancer	5.3e-05	0.000554	CcSEcCtD
Terbinafine—Body temperature increased—Epirubicin—uterine cancer	5.3e-05	0.000554	CcSEcCtD
Terbinafine—Feeling abnormal—Doxorubicin—uterine cancer	5.11e-05	0.000534	CcSEcCtD
Terbinafine—Gastrointestinal pain—Doxorubicin—uterine cancer	5.08e-05	0.00053	CcSEcCtD
Terbinafine—Hypersensitivity—Epirubicin—uterine cancer	4.94e-05	0.000516	CcSEcCtD
Terbinafine—Urticaria—Doxorubicin—uterine cancer	4.93e-05	0.000515	CcSEcCtD
Terbinafine—Abdominal pain—Doxorubicin—uterine cancer	4.91e-05	0.000512	CcSEcCtD
Terbinafine—Body temperature increased—Doxorubicin—uterine cancer	4.91e-05	0.000512	CcSEcCtD
Terbinafine—Asthenia—Epirubicin—uterine cancer	4.81e-05	0.000503	CcSEcCtD
Terbinafine—Pruritus—Epirubicin—uterine cancer	4.75e-05	0.000496	CcSEcCtD
Terbinafine—CYP11A1—Metabolism—STAR—uterine cancer	4.69e-05	0.00124	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.69e-05	0.00124	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.64e-05	0.00123	CbGpPWpGaD
Terbinafine—Diarrhoea—Epirubicin—uterine cancer	4.59e-05	0.000479	CcSEcCtD
Terbinafine—Hypersensitivity—Doxorubicin—uterine cancer	4.57e-05	0.000478	CcSEcCtD
Terbinafine—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	4.52e-05	0.0012	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.48e-05	0.00119	CbGpPWpGaD
Terbinafine—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	4.48e-05	0.00119	CbGpPWpGaD
Terbinafine—Asthenia—Doxorubicin—uterine cancer	4.45e-05	0.000465	CcSEcCtD
Terbinafine—Dizziness—Epirubicin—uterine cancer	4.44e-05	0.000463	CcSEcCtD
Terbinafine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	4.4e-05	0.00116	CbGpPWpGaD
Terbinafine—Pruritus—Doxorubicin—uterine cancer	4.39e-05	0.000459	CcSEcCtD
Terbinafine—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	4.37e-05	0.00116	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	4.35e-05	0.00115	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.31e-05	0.00114	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—NDUFB11—uterine cancer	4.3e-05	0.00114	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—SRD5A2—uterine cancer	4.3e-05	0.00114	CbGpPWpGaD
Terbinafine—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	4.29e-05	0.00114	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.28e-05	0.00113	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.27e-05	0.00113	CbGpPWpGaD
Terbinafine—Vomiting—Epirubicin—uterine cancer	4.26e-05	0.000445	CcSEcCtD
Terbinafine—Diarrhoea—Doxorubicin—uterine cancer	4.25e-05	0.000443	CcSEcCtD
Terbinafine—Rash—Epirubicin—uterine cancer	4.23e-05	0.000442	CcSEcCtD
Terbinafine—Dermatitis—Epirubicin—uterine cancer	4.23e-05	0.000441	CcSEcCtD
Terbinafine—Headache—Epirubicin—uterine cancer	4.2e-05	0.000439	CcSEcCtD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.18e-05	0.00111	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	4.11e-05	0.00109	CbGpPWpGaD
Terbinafine—Dizziness—Doxorubicin—uterine cancer	4.1e-05	0.000429	CcSEcCtD
Terbinafine—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	4.06e-05	0.00107	CbGpPWpGaD
Terbinafine—Nausea—Epirubicin—uterine cancer	3.98e-05	0.000416	CcSEcCtD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	3.95e-05	0.00105	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	3.95e-05	0.00105	CbGpPWpGaD
Terbinafine—Vomiting—Doxorubicin—uterine cancer	3.95e-05	0.000412	CcSEcCtD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.95e-05	0.00104	CbGpPWpGaD
Terbinafine—Rash—Doxorubicin—uterine cancer	3.91e-05	0.000409	CcSEcCtD
Terbinafine—Dermatitis—Doxorubicin—uterine cancer	3.91e-05	0.000408	CcSEcCtD
Terbinafine—Headache—Doxorubicin—uterine cancer	3.89e-05	0.000406	CcSEcCtD
Terbinafine—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	3.88e-05	0.00103	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	3.84e-05	0.00102	CbGpPWpGaD
Terbinafine—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	3.83e-05	0.00101	CbGpPWpGaD
Terbinafine—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	3.83e-05	0.00101	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	3.81e-05	0.00101	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.8e-05	0.00101	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.8e-05	0.00101	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	3.71e-05	0.000983	CbGpPWpGaD
Terbinafine—Nausea—Doxorubicin—uterine cancer	3.69e-05	0.000385	CcSEcCtD
Terbinafine—CYP11A1—Metabolism—POLD1—uterine cancer	3.68e-05	0.000976	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.65e-05	0.000967	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—SRD5A2—uterine cancer	3.62e-05	0.000959	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—NDUFB11—uterine cancer	3.62e-05	0.000959	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—MTHFR—uterine cancer	3.59e-05	0.000951	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	3.57e-05	0.000946	CbGpPWpGaD
Terbinafine—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	3.54e-05	0.000938	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—EP300—uterine cancer	3.54e-05	0.000938	CbGpPWpGaD
Terbinafine—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	3.52e-05	0.000933	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.52e-05	0.000931	CbGpPWpGaD
Terbinafine—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	3.49e-05	0.000925	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	3.47e-05	0.000918	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	3.47e-05	0.000918	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKR1C1—uterine cancer	3.45e-05	0.000912	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.39e-05	0.000897	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.39e-05	0.000897	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	3.37e-05	0.000893	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	3.35e-05	0.000888	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.32e-05	0.000879	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	3.28e-05	0.000869	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	3.24e-05	0.000859	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.18e-05	0.000841	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.16e-05	0.000838	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	3.13e-05	0.000829	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—STAR—uterine cancer	3.11e-05	0.000824	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKR1B1—uterine cancer	3.11e-05	0.000824	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.09e-05	0.000818	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.09e-05	0.000818	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—RRM2—uterine cancer	3.07e-05	0.000813	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	3.03e-05	0.000802	CbGpPWpGaD
Terbinafine—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.99e-05	0.000791	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—DCN—uterine cancer	2.98e-05	0.00079	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.96e-05	0.000783	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	2.85e-05	0.000755	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.79e-05	0.000739	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.79e-05	0.000738	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKR1C3—uterine cancer	2.65e-05	0.000702	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.64e-05	0.000699	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.64e-05	0.000699	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKR1B1—uterine cancer	2.62e-05	0.000693	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—STAR—uterine cancer	2.62e-05	0.000693	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.59e-05	0.000685	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	2.53e-05	0.000671	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.49e-05	0.000659	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—POLD1—uterine cancer	2.44e-05	0.000646	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.37e-05	0.000628	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NDUFB11—uterine cancer	2.34e-05	0.000619	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—SRD5A2—uterine cancer	2.34e-05	0.000619	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.34e-05	0.000619	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.3e-05	0.00061	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKR1C1—uterine cancer	2.28e-05	0.000604	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.27e-05	0.000602	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.27e-05	0.000601	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.15e-05	0.000568	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	2.14e-05	0.000567	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NDUFB11—uterine cancer	2.09e-05	0.000553	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—SRD5A2—uterine cancer	2.09e-05	0.000553	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CYP19A1—uterine cancer	2.07e-05	0.000547	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—STK11—uterine cancer	2.07e-05	0.000547	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—POLD1—uterine cancer	2.05e-05	0.000544	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—RRM2—uterine cancer	2.03e-05	0.000539	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.03e-05	0.000537	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PTEN—uterine cancer	2e-05	0.000529	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—DCN—uterine cancer	1.97e-05	0.000523	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.94e-05	0.000514	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.94e-05	0.000513	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKR1C1—uterine cancer	1.92e-05	0.000509	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.92e-05	0.000508	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.92e-05	0.000508	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.91e-05	0.000507	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—EP300—uterine cancer	1.9e-05	0.000504	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.9e-05	0.000504	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.9e-05	0.000504	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CYP11A1—uterine cancer	1.86e-05	0.000493	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.85e-05	0.00049	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.85e-05	0.00049	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKR1C3—uterine cancer	1.76e-05	0.000465	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.75e-05	0.000462	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—RRM2—uterine cancer	1.71e-05	0.000453	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.69e-05	0.000448	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—STAR—uterine cancer	1.69e-05	0.000448	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.67e-05	0.000443	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—DCN—uterine cancer	1.66e-05	0.00044	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.63e-05	0.000431	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.63e-05	0.000431	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.58e-05	0.000418	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYP11A1—uterine cancer	1.57e-05	0.000415	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—MTHFR—uterine cancer	1.55e-05	0.000411	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—STAR—uterine cancer	1.51e-05	0.0004	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.51e-05	0.0004	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.49e-05	0.000395	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.49e-05	0.000395	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKR1C3—uterine cancer	1.48e-05	0.000392	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PIK3CA—uterine cancer	1.41e-05	0.000373	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.39e-05	0.000368	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—STAR—uterine cancer	1.39e-05	0.000368	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.38e-05	0.000364	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—STAR—uterine cancer	1.38e-05	0.000364	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—STK11—uterine cancer	1.37e-05	0.000363	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.37e-05	0.000362	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.36e-05	0.00036	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—POLD1—uterine cancer	1.33e-05	0.000351	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.28e-05	0.00034	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.26e-05	0.000332	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.26e-05	0.000332	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.24e-05	0.000329	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.23e-05	0.000325	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—POLD1—uterine cancer	1.18e-05	0.000314	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—STAR—uterine cancer	1.18e-05	0.000311	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.18e-05	0.000311	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.16e-05	0.000308	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—STK11—uterine cancer	1.15e-05	0.000305	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYP19A1—uterine cancer	1.15e-05	0.000305	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—AKT1—uterine cancer	1.15e-05	0.000305	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.11e-05	0.000293	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—RRM2—uterine cancer	1.11e-05	0.000293	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—POLD1—uterine cancer	1.09e-05	0.000288	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.08e-05	0.000286	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—POLD1—uterine cancer	1.08e-05	0.000286	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—DCN—uterine cancer	1.07e-05	0.000284	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.03e-05	0.000273	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—MTHFR—uterine cancer	1.03e-05	0.000272	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.02e-05	0.00027	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.01e-05	0.000268	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.01e-05	0.000267	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—RRM2—uterine cancer	9.87e-06	0.000261	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—DCN—uterine cancer	9.58e-06	0.000254	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKR1C3—uterine cancer	9.55e-06	0.000253	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—POLD1—uterine cancer	9.23e-06	0.000244	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—RRM2—uterine cancer	9.08e-06	0.00024	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKR1B1—uterine cancer	9.07e-06	0.00024	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—STAR—uterine cancer	9.07e-06	0.00024	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.07e-06	0.00024	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP11A1—uterine cancer	9.03e-06	0.000239	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—RRM2—uterine cancer	9e-06	0.000238	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—DCN—uterine cancer	8.82e-06	0.000233	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—DCN—uterine cancer	8.74e-06	0.000231	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—MTHFR—uterine cancer	8.66e-06	0.000229	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PTEN—uterine cancer	8.64e-06	0.000229	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKR1C1—uterine cancer	8.63e-06	0.000229	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKR1C3—uterine cancer	8.53e-06	0.000226	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP11A1—uterine cancer	8.3e-06	0.00022	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—EP300—uterine cancer	8.24e-06	0.000218	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP11A1—uterine cancer	8.23e-06	0.000218	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKR1C3—uterine cancer	7.84e-06	0.000208	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKR1C3—uterine cancer	7.78e-06	0.000206	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—RRM2—uterine cancer	7.69e-06	0.000204	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.63e-06	0.000202	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—DCN—uterine cancer	7.47e-06	0.000198	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—STK11—uterine cancer	7.44e-06	0.000197	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP19A1—uterine cancer	7.44e-06	0.000197	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—POLD1—uterine cancer	7.12e-06	0.000189	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP11A1—uterine cancer	7.04e-06	0.000186	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.99e-06	0.000185	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.66e-06	0.000176	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKR1C1—uterine cancer	6.66e-06	0.000176	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKR1C3—uterine cancer	6.64e-06	0.000176	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP19A1—uterine cancer	6.64e-06	0.000176	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—STK11—uterine cancer	6.64e-06	0.000176	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.24e-06	0.000165	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—STK11—uterine cancer	6.11e-06	0.000162	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP19A1—uterine cancer	6.11e-06	0.000162	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CA—uterine cancer	6.09e-06	0.000161	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—STK11—uterine cancer	6.06e-06	0.00016	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP19A1—uterine cancer	6.06e-06	0.00016	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.95e-06	0.000157	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—RRM2—uterine cancer	5.94e-06	0.000157	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—DCN—uterine cancer	5.76e-06	0.000153	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTEN—uterine cancer	5.72e-06	0.000152	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.69e-06	0.000151	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—MTHFR—uterine cancer	5.59e-06	0.000148	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—EP300—uterine cancer	5.46e-06	0.000145	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP11A1—uterine cancer	5.43e-06	0.000144	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.42e-06	0.000144	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—STK11—uterine cancer	5.18e-06	0.000137	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP19A1—uterine cancer	5.18e-06	0.000137	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKR1C3—uterine cancer	5.13e-06	0.000136	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—MTHFR—uterine cancer	4.99e-06	0.000132	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKT1—uterine cancer	4.98e-06	0.000132	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.93e-06	0.000131	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.86e-06	0.000129	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTEN—uterine cancer	4.82e-06	0.000128	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.63e-06	0.000123	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—EP300—uterine cancer	4.59e-06	0.000122	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—MTHFR—uterine cancer	4.59e-06	0.000122	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—MTHFR—uterine cancer	4.55e-06	0.000121	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.4e-06	0.000117	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CA—uterine cancer	4.04e-06	0.000107	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.01e-06	0.000106	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—STK11—uterine cancer	3.99e-06	0.000106	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.99e-06	0.000106	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—MTHFR—uterine cancer	3.89e-06	0.000103	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.43e-06	9.08e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CA—uterine cancer	3.4e-06	9e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKT1—uterine cancer	3.3e-06	8.73e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTEN—uterine cancer	3.11e-06	8.24e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MTHFR—uterine cancer	3e-06	7.95e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—EP300—uterine cancer	2.97e-06	7.86e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTEN—uterine cancer	2.78e-06	7.35e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKT1—uterine cancer	2.78e-06	7.35e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—EP300—uterine cancer	2.65e-06	7.01e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTEN—uterine cancer	2.55e-06	6.76e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTEN—uterine cancer	2.53e-06	6.71e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—EP300—uterine cancer	2.44e-06	6.45e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—EP300—uterine cancer	2.41e-06	6.4e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.19e-06	5.81e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTEN—uterine cancer	2.16e-06	5.73e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—EP300—uterine cancer	2.06e-06	5.46e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.96e-06	5.19e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.8e-06	4.77e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKT1—uterine cancer	1.79e-06	4.75e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.79e-06	4.73e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTEN—uterine cancer	1.67e-06	4.42e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKT1—uterine cancer	1.6e-06	4.24e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—EP300—uterine cancer	1.59e-06	4.22e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.53e-06	4.04e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKT1—uterine cancer	1.47e-06	3.9e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKT1—uterine cancer	1.46e-06	3.86e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKT1—uterine cancer	1.25e-06	3.3e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.18e-06	3.12e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKT1—uterine cancer	9.62e-07	2.55e-05	CbGpPWpGaD
